Escherich CS, Li Z, Barnett KR, Li Y, et al. Differentiation-dependent EBF1 Activity Determines CD22 Transcription and Leukemia Sensitivity to Inotuzumab Ozogamicin. Blood 2025 May 28:blood.2024028215. doi: 10.1182/blood.2024028215.
PMID: 40435412